191 related articles for article (PubMed ID: 23624092)
1. Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis.
Ahn SS; Jeon BY; Park SJ; Choi DH; Ku SH; Cho SN; Sung YC
Vaccine; 2013 Jun; 31(27):2884-90. PubMed ID: 23624092
[TBL] [Abstract][Full Text] [Related]
2. Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models.
Ahn SS; Jeon BY; Kim KS; Kwack JY; Lee EG; Park KS; Sung YC; Cho SN
Gene Ther; 2012 May; 19(5):570-5. PubMed ID: 21956689
[TBL] [Abstract][Full Text] [Related]
3. Marked enhancement of antigen-specific T-cell responses by IL-7-fused nonlytic, but not lytic, Fc as a genetic adjuvant.
Nam HJ; Song MY; Choi DH; Yang SH; Jin HT; Sung YC
Eur J Immunol; 2010 Feb; 40(2):351-8. PubMed ID: 19950168
[TBL] [Abstract][Full Text] [Related]
4. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
[TBL] [Abstract][Full Text] [Related]
5. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
Derrick SC; Yabe IM; Yang A; Morris SL
Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
8. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
10. Construction and immunogenicity of the DNA vaccine of Mycobacterium Tuberculosis dormancy antigen rv1733c.
Zhang W; Jiang H; Bai YL; Kang J; Xu ZK; Wang LM
Scand J Immunol; 2014 May; 79(5):292-8. PubMed ID: 24498941
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses.
Ai W; Yue Y; Xiong S; Xu W
Microbiol Immunol; 2013 Mar; 57(3):224-35. PubMed ID: 23489083
[TBL] [Abstract][Full Text] [Related]
12. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
[TBL] [Abstract][Full Text] [Related]
13. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
Wang QM; Kang L; Wang XH
Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
[TBL] [Abstract][Full Text] [Related]
14. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
Xu J; Xu W; Chen X; Zhao D; Wang Y
Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
[TBL] [Abstract][Full Text] [Related]
15. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.
Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP
Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.
Derrick SC; Yang AL; Morris SL
Infect Immun; 2005 Nov; 73(11):7727-35. PubMed ID: 16239577
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
19. A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge.
Gao H; Yue Y; Hu L; Xu W; Xiong S
Vaccine; 2009 Aug; 27(39):5313-9. PubMed ID: 19615961
[TBL] [Abstract][Full Text] [Related]
20. A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector.
Yu DH; Li M; Hu XD; Cai H
Vaccine; 2007 Sep; 25(37-38):6744-54. PubMed ID: 17681650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
